Frontlight ResearchEarly access
Taking people in United StatesPhase 4
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
Key facts
- Who runs it
- Berkeley Eye Center
- Where
- Houston and Plymouth Meeting, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 320 people, planned
- Started
- 17 Mar 2025
- Expected to end
- Apr 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Clareon PanOptix
- Clareon PanOptix PRO
- Mix-and-Match PanOptix/Vivity
- Record updated
- 30 September 2026
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Adult cataract patients aged 40 years and older scheduled for age related cataract surgery in both eyes
- Ability to understand and sign an ethics committee-approved informed consent form
- Willingness and ability to attend all scheduled study visits as required by the protocol
- Postoperative potential visual acuity of 20/25 or better in each eye, as determined by the investigator
- Preoperative corneal astigmatism that can be corrected with a T3 or T4 toric IOL, or with a spherical IOL and LRIs or AKs resulting in a predicted postoperative astigmatism of less than 0.5 diopters (D)
- Ability to understand and complete questionnaires
Who cannot take part
- Prior ocular surgery (except for uncomplicated cataract surgery in the fellow eye)
- Ocular conditions that could confound study results, including moderate to severe corneal pathology, irregular astigmatism, moderate to severe dry eye, preexisting retinal diseases such as macular degeneration or diabetic retinopathy
- Systemic conditions that may affect healing or visual outcomes (e.g., uncontrolled diabetes mellitus, certain autoimmune disorders)
- Any active ocular infection or inflammation (except for routine post-operative inflammation in the fellow eye)
- Psychiatric or cognitive disorders that may impair the ability to comply with study procedures or provide accurate self-assessments
- Women who are pregnant, planning to become pregnant during the study, or breastfeeding
- Any form of confirmed glaucomatous damage (ie, mild, moderate, or severe glaucoma)
- Participation in another clinical study that could interfere with the results
- Subjects with nystagmus, strabismus, zonular laxity or dehiscence, and pseudoexfoliation
- Participants desiring monovision
- RMS total higher-order aberrations (HOAs) >0.70 µm or coma >0.40 µm as measured by tomography or topography with a 4 mm pupil setting
This trial is currently available in United States.
- Berkeley Eye CenterHouston, United StatesContact: Tetiana HuffTaking people
- Shafer Vision InstitutePlymouth Meeting, United StatesContact: Ailinn DunnTaking people
About the trial
What the trial wants to find out
Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
The 3 groups in the trial
- Bilateral Clareon PanOptix IOL implantationExisting treatment, for comparison
Treatment: Clareon PanOptix
- Bilateral Clareon PanOptix Pro IOL implantationTreatment being tested
Treatment: Clareon PanOptix PRO
- Clareon PanOptix Pro in the non-dominant eye and Clareon Vivity in the dominant eyeTreatment being tested
Treatment: Mix-and-Match PanOptix/Vivity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 September 2026